I 
114TH CONGRESS 
1ST SESSION H. R. 3092 
To provide for the issuance of an Alzheimer’s Disease Research Semipostal 
Stamp. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 16, 2015 
Ms. MAXINE WATERS of California (for herself, Mr. SMITH of New Jersey, 
Mr. FATTAH, Mr. GARAMENDI, Mrs. BEATTY, Mr. BRENDAN F. BOYLE 
of Pennsylvania, Mr. BRADY of Pennsylvania, Ms. BROWN of Florida, Ms. 
CLARK of Massachusetts, Ms. CLARKE of New York, Mr. COHEN, Mr. 
CONNOLLY, Mr. DELANEY, Mrs. DINGELL, Mr. DOGGETT, Ms. 
EDWARDS, Ms. FRANKEL of Florida, Mr. GRIJALVA, Ms. HAHN, Mr. 
HASTINGS, Mr. HIGGINS, Mr. ISRAEL, Ms. JACKSON LEE, Mr. JOHNSON 
of Georgia, Mr. KEATING, Ms. KELLY of Illinois, Mrs. LAWRENCE, Ms. 
LEE, Mr. LEWIS, Mr. LYNCH, Ms. MATSUI, Mr. MCGOVERN, Mr. NAD-
LER, Ms. NORTON, Mr. PAYNE, Mr. POLIS, Mr. RANGEL, Ms. LINDA T. 
SA´NCHEZ of California, Ms. LORETTA SANCHEZ of California, Ms. SCHA-
KOWSKY, Mr. DAVID SCOTT of Georgia, Mr. SIRES, Mr. TONKO, Mr. VAN 
HOLLEN, Mrs. WATSON COLEMAN, Mr. LIPINSKI, and Mr. PETERS) in-
troduced the following bill; which was referred to the Committee on Over-
sight and Government Reform, and in addition to the Committee on En-
ergy and Commerce, for a period to be subsequently determined by the 
Speaker, in each case for consideration of such provisions as fall within 
the jurisdiction of the committee concerned 
A BILL 
To provide for the issuance of an Alzheimer’s Disease 
Research Semipostal Stamp. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
00:45 Jul 21, 2015
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3092.IH
H3092
smartinez on DSK4TPTVN1PROD with BILLS
SECTION 1. ALZHEIMER’S DISEASE RESEARCH SEMIPOST-
AL STAMP. 
(a) IN GENERAL.—In order to afford a convenient 
way for members of the public to contribute to funding 
for medical research relating to Alzheimer’s disease, the 
United States Postal Service shall issue a semipostal 
stamp (referred to in this Act as the ‘‘Alzheimer’s Disease 
Research Semipostal Stamp’’) in accordance with the pro-
visions of this section. 
(b) TERMS AND CONDITIONS.— 
(1) IN GENERAL.—The issuance and sale of the 
Alzheimer’s Disease Research Semipostal Stamp 
shall be governed by the provisions of section 416 of 
title 39, United States Code, and regulations issued 
under such section, subject to the requirements of 
this subsection. 
(2) DURATION.—The Alzheimer’s Disease Re-
search Semipostal Stamp shall be made available to 
the public for a period of 6 years, beginning no later 
than 12 months after the date of the enactment of 
this Act. 
(3) DISPOSITION OF PROCEEDS.—All amounts 
becoming available from the sale of the Alzheimer’s 
Disease Research Semipostal Stamp (as determined 
under section 416(d) of such title 39) shall be trans-
ferred to the National Institutes of Health, for the 
VerDate Sep 11 2014 
00:45 Jul 21, 2015
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3092.IH
H3092
smartinez on DSK4TPTVN1PROD with BILLS
purpose described in subsection (a), through pay-
ments which shall be made at least twice a year. 
(c) DEFINITION.—For purposes of this Act, the term 
‘‘semipostal stamp’’ refers to a stamp described in section 
416(a)(1) of title 39, United States Code. 
Æ 
VerDate Sep 11 2014 
00:45 Jul 21, 2015
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H3092.IH
H3092
smartinez on DSK4TPTVN1PROD with BILLS